Maxis Clinical Sciences

Maxis Clinical Sciences

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Founded in 2018 and headquartered in London, Maxis Clinical Sciences (MCS) operates as a strategic advisory and services firm at the intersection of clinical research and digital health. The company provides integrated solutions centered on real-world evidence (RWE), data standardization (e.g., OMOP CDM), and AI to help pharma and biotech clients enhance clinical trial efficiency, demonstrate value, and personalize patient care. With a team of over 300 industry experts and a claimed track record of supporting 3,000+ clinical trials, MCS positions itself as a specialized partner for accelerating evidence generation and navigating the complexities of modern drug development.

Oncology

Technology Platform

Integrated suite of data and AI solutions centered on Real-World Evidence (RWE) generation, including expertise in the OMOP Common Data Model (CDM) for data standardization, clinical trial tokenization for data integration, health economic modeling, and advisory on AI/GenAI adoption in pharma.

Opportunities

The growing regulatory acceptance of Real-World Evidence (RWE) for drug approvals and label expansions creates strong demand for specialized consulting services.
Additionally, the industry's push towards digital transformation and AI adoption in clinical development presents a significant adjacent market for expert advisory.

Risk Factors

High dependence on pharmaceutical R&D spending cycles and intense competition from large global CROs and other boutique firms.
The company also faces the ongoing challenge of attracting and retaining specialized talent in a competitive market.

Competitive Landscape

MCS competes in a fragmented market with large, full-service Contract Research Organizations (CROs) like IQVIA and Parexel, as well as numerous other boutique clinical and RWE consulting firms. Its differentiation is based on deep domain expertise, a strategic advisory focus, and niche technical capabilities in data standardization and AI.